Just when Meng Qian was concerned about this problem and thinking about countermeasures, the United States poked the basket again: the Department of Justice asked the FBI to arrest two Chinese experts engaged in biological cell research. It accuses them of providing China with core biogenetic technology, as well as related high-end medical device technology.

After Meng Qian read the report, he felt ridiculous, he did not know whether the former's biotechnology was secret, but the latter's equipment was also available in China -- the US Department of Justice was busy prosecuting and arresting people without consulting experts, which showed that they were targeting Chinese Americans and had strong political implications.

Meng Qian looked at the related Chinese spy news in previous years, and there were really a lot of them, but in the end, there was almost no conclusive evidence - every time after someone was arrested, he could not provide evidence and withdrew the charges, but it was precisely because of this kind of oolong behavior that everyone of Chinese American scientists was in danger.

The U.S. strategy based on the "China threat" will make its government very sensitive. But if they do so, the crisis of trust and the consequences will coexist. Meng Qian is now considering his stem cell research in the United States, which has something to do with the technology of the Chinese scientists who were arrested this time.

Although the entire research was privately invested by him, it took place on American soil, and also used some American technology and equipment, and if the Department of Justice believes that it is suspicious, it is possible to carry out surveillance and arrest. He brought those experts with him, and he had to be accountable to them.

It is not only him who is concerned about this series of things, but also the government of his country.

Later, when Meng Qian went to Beijing to discuss the construction of the stem cell industry, some people suggested that he withdraw the research team, and China can provide a good environment.

Meng Qian knew that the country was paying attention to his actions, but there were too many things involved, and he got the team out at the beginning. It is the convenience of borrowing foreign professionals and research resources; Zhang Dongliang intends to combine foreign technology and domestic foundation to improve the high-end level of China.

And then based on business considerations. The promotion of stem cell technology has always been the mainstream of consumption in Europe and the United States. Just like a few of his new medicines. The consumption potential of European and American countries is huge. If you go back, if you want to go out in the future, you will have to repeat the path you have taken, and it will be even more troublesome.

Therefore, Meng Qian refused for other reasons, only negotiated the plan of stem cell production and cultivation, it is also a huge industry, if you maintain the leading technology, the world will buy stem cells from here in the future or technology licensing, and it can also promote technical exchanges at home and abroad.

After these things are done. Meng Qian was busy rushing abroad.

He wanted to hear the opinions of the Chinese experts and respect their choice.

Back in San Francisco, he convened a meeting of researchers of Chinese or Chinese descent.

The dark cloud of espionage does hang over their heads, and although it has not yet happened to everyone, it is always like a time bomb from the perspective of the US government's approach.

Experts led by Zhang Dongliang expressed concern: "We can't figure out what the Americans think, what if we are 'crossed the line' in the future?" ”

Meng Qian assured them: "I will talk to the Americans about this issue, and I brought you out." I won't let your reputation be tarnished easily. ”

"We are not worried about being accused of commercial espionage, but we are now in a critical stage of stem cell medicine and cannot stop," Zhang said. ”

"I know." Meng Qian knew that the desire of these people to pursue academics and achievements was above all else, so he asked, "If I want to change the environment." What do you think? ”

"Can the domestic conditions keep up?" There are expert questions.

"I didn't say it was domestic." "I mean, if it's possible, go to Europe or somewhere else. Is it a big impact on the study as a whole? ”

Zhang Dongliang said: "The conditions for medical research in Europe are also at the forefront, and there are pharmaceutical and research giants in Switzerland or the United Kingdom. France is not bad, but there has been too much terror lately. ”

"Not France. Insecurity. Meng Qian also had to consider security factors, as well as language issues.

In addition, he considers the business factor.

This is what he did not tell the expert team, and the business factors are mainly on tax issues, such as the American pharmaceutical giant Pfizer, which has repeatedly wanted to merge and acquire overseas pharmaceutical giants, implement "tax inversion", move its headquarters abroad, and reduce the heavy tax burden in the United States.

Pfizer should be in a hurry now, after its failed attempt to buy the UK's AstraZeneca in 2014, it was rumored that it wanted to spend nearly $150 billion to buy the UK's GSK; This year, it was once again rumored that it wanted to acquire Ireland's "Allergan Company", which was also hundreds of billions of dollars.

Not only is Pfizer so anxious to flee the United States, but the same pharmaceutical giant AbbVie has also planned to spend $55 billion to buy Shire in order to enjoy the low 13% tax rate in Jersey, England...... But in the end, it failed due to the obstruction of the US government.

These giants are desperate to escape, which also affects Meng Qian to a certain extent.

He spoke on the phone with Mrs. Stone, who was also in the pharmaceutical industry and had a more strategic vision.

Elektra. After listening to his doubts, Stone agreed: "Based on tax considerations alone, it would be better for the pharmaceutical industry to choose a more suitable place to register its headquarters." ”

Meng Qian asked, "What about yours?" ”

Erica said: "Although Onix Pharmaceutical is registered in the United States, the group that holds the majority of its shares is overseas, and the United States can only control its domestic affairs, whether in terms of management and taxation. ”

It turns out that they are all shrewd! Meng Qian said: "It is also necessary to consider the issue of transfer. ”

"England is a nice place to be." Erica advises, "Both the consortium and the fraternity have a good local presence, and the research environment is good. ”

"Thank you, ma'am, I'll think about it." Meng Qian said.

After putting down the phone, he picked it up and dialed the number again, and talked with a politician about the attitude of the Department of Justice and even the United States on this issue, whether he could suffer and so on.

Although the other side has pledged that the United States will not interfere with private companies and their research, they will also reflect and demand that the government be cautious.

But Meng Qian could hear that the other party was not sure about these things, which may not only be a policy, but a deep-rooted in the consciousness of politicians, and it is difficult for a few people to influence the general environment.

It's as if the FBI is still rude and unreasonable. The agents below are subconsciously wary of a certain group and have bad intentions.

Putting down the phone again, Meng Qian frowned.

"If it doesn't work here, we'll change places." Wang Manwen sat down and said, "The pharmaceutical industry will account for a high proportion of revenue in the future, and the overall situation should be considered. ”

"Hmm." Meng Qian nodded, "It is inevitable to let the pharmaceutical industry and research leave the United States, and I have not yet developed to the point of praying for them to give space for development." ”

Wang Manwen could feel his thoughts: "The stem cell clinical practice has achieved remarkable results, and with the clinical performance of four new drugs, the rest of the Western countries will treat you as the God of Wealth." ”

The capitalist society is so realistic, the United States does not provide a good environment for capital, making him feel insecure, why did Meng Qian choose them? Pay so much tax?

If you don't give me a good environment, I'll leave!

In terms of operating procedures, the industry under Meng Qian's hands is too easy. It's so easy that companies like Pfizer and AbbVie want to cry. It was originally a large proportion of offshore companies, and the Marsh Group held 70% of the shares of Montmount Pharmaceutical and 70% of Wells Fargo Pharmaceutical, which was easy to transfer.

Wang Manwen also sent her analysis.

"Britain?" Meng Qian got the same answer as Erica.

Although Britain has declined, it still has advantages, otherwise it would not be a developed country. They are still leading in the pharmaceutical and aviation industries. Meng Qian is interested in the pharmaceutical industry, and the UK also has a good environment, and giants such as AstraZeneca and GSK are British.

So he was going to probe first.

Meng Qian used his consortium and brotherhood connections to start a telephone conversation with the business function in the United Kingdom.

Because there is foreshadowing first, the other party understands that it is about stem cells and new drugs. Meng Qian said that he intends to invest in the UK and set up a pharmaceutical research company, and asked about changing the place of registration to obtain tax incentives, and what kind of care he can get in terms of treating large investments.

That's right, Meng Qian is asking for favors from the British.

But he has the confidence to ask for preferential treatment and care, because this business is something that any country would value.

After the person in charge discussed with him, it was then reached to the prime minister through the cabinet relationship, and a temporary investment promotion team was formed to be responsible for liaising with the senior personnel of the Meng Group. This is a 100 billion dollar industry, and the other party also invited him to visit the UK in person. (To be continued.) )